Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 152 results found. Search for [ Active Pharmaceutical Ingredients ]

Results 1 to 21 of 152
PTI
November 18, 2019
The significant violations included failure to have adequate written procedures for the receipt, identification, testing and handling of raw materials


PTI
November 18, 2019
Prasad said there was a need for the government to focus on and invest more in primary healthcare


PB Jayakumar
New Delhi, November 7, 2019
Lupin's net sales for the quarter stood at Rs 4,296 crore, an increase of 10.4 per cent compared to Rs 3,890 crore in the Q2FY19. The company posted a net loss of Rs 127 crore (after exceptional items) in Q2FY20, compared to Rs 266 crore net profit during the same quarter of the previous year


PB Jayakumar
November 6, 2019
Most violations relate to rectifiable documentation, data maintenance, batch-wise consistent production quality, data on supply chain, stability issues, microbial contamination and quality checks


BusinessToday.In
November 4, 2019
Hikal share price gained up to 9.51% to Rs 131.90 compared to the previous close of Rs 120.45 on BSE


PTI
October 25, 2019



Joe C Mathew
New Delhi, October 25, 2019
Nano-formulations are not entirely new drugs but medicines that have better quality because of the technology-led delivery mechanisms that are used to make its administration in the body more effective


PB Jayakumar
October 1, 2019
The communication also directed the state-level authorities to communicate to the DCGI at the earliest on the action initiated by them.


PTI
August 25, 2019



PTI
July 8, 2019



BusinessToday.In
June 24, 2019
Glenmark Pharma's shares opened 5 points down at Rs 495 after forming a gap down chart pattern at the opening bell, against the last close of Rs 500


E Kumar Sharma
New Delhi, June 20, 2019
The Indian pharmaceutical industry players believe it is high time for the government to articulate a clear blueprint to support manufacturing and research


E Kumar Sharma
New Delhi, June 10, 2019
Drug regulatory reforms in China have turned the heat on the Indian pharmaceutical industry and raised the cost of bulk drugs. But some firms have managed to turn the crisis into an opportunity by filling in the space left by the Chinese.


PTI
May 31, 2019



PTI
May 17, 2019
Revenue for the quarter under discussion was up by 14 per cent at Rs 4,016.60 crore against Rs 3,534.90 crore in the same quarter last fiscal, the city-based drug-maker said in a press release.


PTI
May 7, 2019



PTI
May 7, 2019



PTI
April 24, 2019



PTI
April 19, 2019



BusinessToday.In
March 11, 2019
Unichem Laboratories share price has risen 3.69% during the last three days. It has lost 39% during the last one year and gained 7% since the beginning of this year.


PAGES 1 OF 8  12345